Financials
- Financial year
- 2025
- Total assets
- €207,113
- Profit
- €102,376
- Solvency
- 86.0%
Total assets▲ 124%
Net result
20232025
Dr. L. MANCEL
ActiveSummary
Dr. L. MANCEL has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €178,068 and a net result of €102,376. Equity is growing by about 110% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.4% (very low).
Overview
Activity
“De uitoefening van de geneeskunde door de artsen,zijnde uitsluitend artsen die op de lijst…” (deed in Dutch)
From the articles, 4 activitiesNo NACE code in the KBO yet1 site
Size
€207,113total assets 2025
- Equity
- €178,068
- Profit
- €102,376
Turnover not published (abbreviated format)
Structure
- MANCEL Leander Paul StefaanDirector
2025 accounts 122 days early
Why 89raises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 6.82, cash €176,328Size: total assets €207,113Figures for financial year 2025 (filed 02-04-2026)Show the evidence
Checked score
Score 2025
89
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 88% of its sector peers (no NACE code, micro)
Financial strength · tick = 2024
Strong
Solvency
100=
equity 86.0% of total assets
Liquidity
97+2
short-term debt 14.0% · cash 85.1%
Profitability
100=
return on assets 49.4%
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.6%
12-2024: 0.6%● unchanged vs 11-2024
01-2025: 0.6%● unchanged vs 12-2024
02-2025: 0.6%● unchanged vs 01-2025
03-2025: 0.6%● unchanged vs 02-2025
04-2025: 0.6%● unchanged vs 03-2025
05-2025: 0.7%▲ +0.1 percentage points vs 04-2025
06-2025: 0.7%● unchanged vs 05-2025
07-2025: 0.8%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 0.2%▼ -0.6 percentage points vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.3%▲ +0.1 percentage points vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.1%▼ -0.2 percentage points vs 04-2026lowest value
06-2026: 0.4%▲ +0.3 percentage points vs 05-2026
07-2026: 0.4%● unchanged vs 06-2026
08-2026: 0.4%● unchanged vs 07-2026
09-2026: 0.4%● unchanged vs 08-2026
10-2026: 0.4%● unchanged vs 09-2026
Credit of up to €15,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 6.82, compared with 4.76 in 2024, above the usual 1.5; short-term debt: 14% and cash: 85.1% of total assets), and 14% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 88% on liquidity, 90% on profitability and 94% on growth.
The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2023, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-03-2026, 122 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
122 days early
2024
31 days early
2023
48 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 3 accounts on average 67 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 June (3 of the last 3 filed years within 75 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
- Registered officeRegistered-office move
- Annual accounts filedfinancial year 2025 · abbreviated…
- Highest result from 2023 to 2025net €102,376 ▲59.5%
Key points
By topic
Board & ownership
- Board
- 1 member
- MANCEL Leander Paul StefaanDirector
Timeline
- Events
- 7
- Since
- 2023
- Next accounts
- by 31-07-2027
- 31-12-2025Equity above €150,000
- 30-06-2025Annual accounts filed
- 13-06-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Founded
- 27-10-2023
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 20
- Annual meeting
- Last Wednesday of June at 14:00
- Purpose
- “De uitoefening van de geneeskunde door de artsen,zijnde uitsluitend artsen die op de lijst…” (deed in Dutch)
Key facts about Dr. L. MANCEL
- What is the company number of Dr. L. MANCEL?
- 1001.712.169. In Belgium the VAT number is the company number with BE in front: BE 1001.712.169.
- Where is Dr. L. MANCEL based?
- The registered office is at Lotelingstraat(MZN) 5, 2812 Mechelen.Company details
- What is the legal form of Dr. L. MANCEL?
- Private limited company (BV).
- When was Dr. L. MANCEL founded?
- On 27-10-2023.
- Is Dr. L. MANCEL still active?
- Yes, Dr. L. MANCEL is an active enterprise in the KBO register.
- What is the turnover of Dr. L. MANCEL?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is Dr. L. MANCEL profitable?
- In financial year 2025, Dr. L. MANCEL made a profit of €102,376.
- Where can I find the annual accounts of Dr. L. MANCEL?
- Dr. L. MANCEL filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. L. MANCEL due?
- By 31-07-2027, for financial year 2026.Timeline
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.